Association between reduced risk of gastrointestinal bleeding related to proton pump inhibitor use and subsequent all-cause death in patients with percutaneous coronary intervention
Event:
ESC Congress 2024
Topic:
Epidemiology, Prognosis, Outcome
Session:
Risk stratification in percutaneous coronary intervention (3)
Effect of rivaroxaban monotherapy vs. combination with anti-platelet therapy in patients with atrial fibrillation and stable coronary artery disease across different body mass index categories